Wednesday, December 1, 2021
HomeNewsDRDO's Anti-Covid Drug: 2-deoxy-D-glucose Launched!

DRDO’s Anti-Covid Drug: 2-deoxy-D-glucose Launched!

Protection Minister Rajnath Singh on Monday (May 17, 2021) released the initial set of the anti-COVID-19 medicine 2-deoxy-D-glucose (2-DG) to strengthen India’s fight versus the coronavirus. Union Health And Wellness Minister Harsh Vardhan and also AIIMS Delhi Director Dr Randeep Guleria were also present throughout the release.

Over 10,000 dosages of the 2-DG medicine, which comes in powder type and also is taken orally by liquifying it in water, were launched.

Also, check out Blood Moon 2021: Date & Time!

What is DRDO’s 2-deoxy-D-glucose: Is it approved?

Earlier this month, the Drugs Controller General of India (DGCI) has approved oral medicine for emergency usage as an accessory treatment in moderate to serious coronavirus clients.

The approval of the medication has actually come at a time when India is coming to grips with a record-breaking wave of the coronavirus pandemic that has stretched the nation’s medical care framework to its limitation.


DRDO chairman Dr G Satheesh Reddy stated that DRDO and also Dr Reddy’s laboratory had undergone the full tests and also carried out tests throughout 30 medical facilities and also on a lot of people.
The medication is available in powder type in a sachet.

The authorization of the medication has actually come with a time when India is coming to grips with a record-breaking wave of the coronavirus pandemic that has actually extended the nation’s health care facilities to its limitation.

” In the ongoing second COVID-19 wave, a lot of individuals are dealing with serious oxygen dependency and also require hospitalization. The medicine is anticipated to save valuable lives due to the device of its procedure in the contaminated cells. This also minimizes the hospital remain of COVID-19 clients,” the ministry had said.

The anti-COVID restorative application of the medicine has been established by the Institute of Nuclear Medication and also Allied Sciences (INMAS), a leading laboratory of the DRDO, in partnership with Dr Reddy’s Laboratories (DRL) in Hyderabad.

How to Take New Anti-Covid Drug 2-DG?

The anti-COVID medicine 2-DG has actually been created in powder type and also is consumed by mouth by liquifying it in water. According To Dr. Sudhir Chandna, DRDO Job Supervisor as well as Scientist of 2-DG, it can be eaten two times a day.

A patient might have to take this drug twice a day for about 5 to 7 days. However, it should be taken in just on the suggestions of a physician.

DRDO’s 2-DG Anti Covid Drug?

The final rate of 2-DG has not been finalized as yet. It will certainly be established by the DRDO companion Dr Reddy’s, which is producing the medicine. It is, nevertheless, believed to be an economical medication.

Also, Check out PUBG Mobile India Release Date!

How Does 2-deoxy-D-glucose Drug Works?

Clarifying how the vaccination functions, Reddy stated, “It functions directly on the cells contaminated with COVID and also gets soaked up in them. It after that stops the infection from increasing and also relocating to other healthy cells.

It additionally services the immune system of the patient to ensure that the person can recuperate immediately.” The individual needs to take the vaccine two times a day for around five to 7 days. It also relies on the person’s weight and also medical professional’s prescription, he added.

DRDO & Dr. Reddy’s 2-deoxy-D-glucose Trail Data:

The phase 2 medical tests were executed to examine the security and also efficacy of the medicine in Covid-19 people. 2-DG was discovered to be secure in Covid-19 people, as well as revealed considerable renovation in their recovery, the government launch said.

Inefficiency fads, “the patients treated with 2-DG revealed much faster symptomatic cure than Requirement of Treatment (SoC) on numerous endpoints”, the launch said. ” A substantially favorable fad (2.5 days distinction) was seen in terms of the average time to achieving normalization of particular crucial signs criteria when contrasted to SoC.”

Information from the phase 3 scientific test revealed that in the 2-DG arm, a “dramatically higher proportion of clients boosted symptomatically as well as became devoid of additional oxygen dependence (42% vs 31%) by Day 3 in contrast to SoC, indicating a very early remedy for oxygen therapy/dependence”, the federal government claimed.


Most Popular